newsfilter
← Latest News
ClinicalTrials.gov·

Myasthenia Gravis Inebilizumab Trial - NCT04524273

Change from baseline in Myasthenia Gravis Activities of Daily Living (MG-ADL) Profile score., Change in Quantitative Myasthenia Gravis (QMG) scores., Proportion of subjects with both (1) ≥ 3-point improvement in MG-ADL and (2) no use of rescue therapy., (and 6 more...)